Newly leaked confidential documents from Pfizer have revealed that the pharmaceutical company was aware of the risk of myocarditis following doses of their COVID-19 vaccine in early 2022, according to a report from Project Veritas.
Myocarditis is inflammation of the heart muscle that can affect the heart’s ability to function properly.
The documents contain several quotes that suggest a correlation between the vaccine and the heart condition.
“There is evidence that suggests patients who receive a COVID-19 vaccine are at an increased risk of myocarditis,” one quote from the documents states.
Another quote reveals that “onset was typically within several days after mRNA COVID-19 vaccination (from Pfizer or Moderna), and cases have occurred more often after the second dose than the first dose.”
The documents note that cases of myocarditis and pericarditis, inflammation of the heart muscle and lining, have been reported more frequently in young adults and adolescents since April 2021.
“Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna), particularly in adolescents and young adults (CDC 2021),” another excerpt reads.
The incidence rates of myocarditis were also measured for each vaccine dose, with the denominator signifying the total number of patients receiving that dose and numerator signifying the total number of patients meeting the criteria for an encounter with myocarditis following that dose.
“Myocarditis events were defined as encounters with a billing or encounter diagnosis consistent with an ICD10-CM or SNOMED CT code for myocarditis which fell within two weeks of receiving dose 1, 2, or 3 of the Pfizer COVID-19 vaccine,” the documents explain.
The leaked documents also note that the pattern of cases conforms to a pattern of myocarditis cases occurring in the majority of young males below 29 years of age within the first two weeks post-vaccination.
“The pattern of cases conform, as per the label, to a pattern of myocarditis cases occurring in majority of young males below 29 years of age within the first two weeks postvaccination,” the documents say.
However, the reasons for male predominance in incidence remain unknown.
“The reasons for male predominance in myocarditis and pericarditis incidence post COVID-19 vaccination remain unknown,” the documents state.”
There have been more than 1,500,000 COVID vaccine-linked injuries reported to the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) and more than 35,000 deaths.